M. Previti

700 total citations
18 papers, 306 citations indexed

About

M. Previti is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, M. Previti has authored 18 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Genetics and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in M. Previti's work include Diabetes and associated disorders (11 papers), Pancreatic function and diabetes (11 papers) and Glycosylation and Glycoproteins Research (5 papers). M. Previti is often cited by papers focused on Diabetes and associated disorders (11 papers), Pancreatic function and diabetes (11 papers) and Glycosylation and Glycoproteins Research (5 papers). M. Previti collaborates with scholars based in Italy, United States and South Africa. M. Previti's co-authors include Domenico Cucinotta, E. Di Cesare, Francesco Dotta, Umberto Di Mario, Luisa Lenti, George S. Eisenbarth, S. Dionisi, Maria D’Erme, Giovanni Raimondo and L. Lenti and has published in prestigious journals such as Diabetes, Endocrinology and Annals of the New York Academy of Sciences.

In The Last Decade

M. Previti

18 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Previti Italy	12	141	140	134	64	45	18	306
Yiting Song Sweden	8	98 0.7×	82 0.6×	110 0.8×	87 1.4×	17 0.4×	17	338
B. Z. Alizadeh Netherlands	10	110 0.8×	176 1.3×	108 0.8×	29 0.5×	41 0.9×	10	329
G Feifel Germany	8	99 0.7×	103 0.7×	120 0.9×	61 1.0×	42 0.9×	25	360
Mayumi Enya Japan	10	153 1.1×	191 1.4×	100 0.7×	172 2.7×	44 1.0×	22	388
Soichi Takizawa Japan	8	238 1.7×	220 1.6×	166 1.2×	61 1.0×	84 1.9×	12	439
H J Peter Switzerland	10	66 0.5×	91 0.7×	262 2.0×	127 2.0×	24 0.5×	18	429
Alexander N. Parker United States	4	48 0.3×	88 0.6×	48 0.4×	74 1.2×	44 1.0×	5	287
R Hintz United States	6	50 0.4×	124 0.9×	259 1.9×	237 3.7×	56 1.2×	12	444
Marta Bellodi‐Privato Brazil	11	79 0.6×	67 0.5×	22 0.2×	90 1.4×	71 1.6×	18	322
D. J. Kortleve Netherlands	7	94 0.7×	110 0.8×	472 3.5×	291 4.5×	15 0.3×	11	579

Countries citing papers authored by M. Previti

Since Specialization

Citations

This map shows the geographic impact of M. Previti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Previti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Previti more than expected).

Fields of papers citing papers by M. Previti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Previti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Previti. The network helps show where M. Previti may publish in the future.

Co-authorship network of co-authors of M. Previti

This figure shows the co-authorship network connecting the top 25 collaborators of M. Previti. A scholar is included among the top collaborators of M. Previti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Previti. M. Previti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Romeo, Elisabetta L., M. Previti, Annalisa Giandalia, Giuseppina Russo, & Domenico Cucinotta. (2016). Ulcero-osteolytic lesions in a woman with type 2 diabetes and carpal tunnel syndrome: A case report and literature review. Diabetes Research and Clinical Practice. 113. 204–207. 1 indexed citations

2.

Russo, Giuseppina, A. Di Benedetto, Domenico Magazzù, et al.. (2009). Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study. Acta Diabetologica. 48(2). 95–101. 24 indexed citations

3.

Perriello, G., Simone Pampanelli, Francesca Porcellati, et al.. (2005). Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double‐blind and cross‐over trial. Diabetic Medicine. 22(5). 606–611. 43 indexed citations

4.

Lasco, Antonino, Agostino Gaudio, N. Morabito, et al.. (2004). Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women. Diabetologia. 47(3). 571–574. 16 indexed citations

5.

Cesare, E. Di, et al.. (2004). Prevalence of Autoantibodies to Carbonic Anhydrase II and Lactoferrin in Patients with Type 1 Diabetes. Annals of the New York Academy of Sciences. 1037(1). 131–132. 10 indexed citations

6.

Squadrito, Giovanni, M. Previti, Marco Lenzi, et al.. (2003). High Prevalence of Non-Organ-Specific Autoantibodies in Hepatitis C Virus-Infected Cirrhotic Patients from Southern Italy. Digestive Diseases and Sciences. 48(2). 349–353. 13 indexed citations

7.

Cesare, E. Di, et al.. (2001). Serum anti-p53 autoantibodies in patients with type 1 diabetes.. PubMed. 31(3). 253–8. 10 indexed citations

8.

Dotta, Francesco, M. Previti, Marguerite Neerman‐Arbez, et al.. (1998). The GM2-1 Ganglioside Islet Autoantigen in Insulin-Dependent Diabetes Mellitus Is Expressed in Secretory Granules and Is Notβ -Cell Specific*. Endocrinology. 139(1). 316–319. 15 indexed citations

9.

Cavallo, Maria Gisella, Francesco Dotta, L. Monetini, et al.. (1996). Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells. Journal of Endocrinology. 150(1). 113–120. 19 indexed citations

10.

Cesare, E. Di, M. Previti, Francesco Paolo Russo, et al.. (1996). Interferon-α therapy May induce insulin autoantibody development in patients with chronic viral hepatitis. Digestive Diseases and Sciences. 41(8). 1672–1677. 41 indexed citations

11.

Dotta, Francesco, Roberto Gianani, M. Previti, et al.. (1996). Autoimmunity to the GM2-1 Islet Ganglioside Before and at the Onset of Type I Diabetes. Diabetes. 45(9). 1193–1196. 23 indexed citations

12.

Dotta, Francesco, M. Previti, L. Lenti, et al.. (1995). GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia. 38(9). 1117–1121. 26 indexed citations

13.

Bagnato, Gianfilippo, et al.. (1995). Gastric mucosal mast cells in atopic subjects. Allergy. 50(4). 322–327. 12 indexed citations

14.

Dotta, Francesco, M. Previti, L. Lenti, et al.. (1995). GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia. 38(9). 1117–1121. 2 indexed citations

15.

Cesare, E. Di, et al.. (1994). High serum levels of soluble CD8 in insulin-dependent diabetes. Clinical & Experimental Immunology. 95(2). 283–286. 11 indexed citations

16.

Dotta, Francesco, Claudio Tiberti, M. Previti, et al.. (1993). Rat Pancreatic Ganglioside Expression: Differences between a Model of Autoimmune Islet B Cell Destruction and a Normal Strain. Clinical Immunology and Immunopathology. 66(2). 143–149. 16 indexed citations

17.

Previti, M., Francesco Dotta, G. M. Pontieri, Umberto Di Mario, & Luisa Lenti. (1992). Determination of gangliosides by high-performance liquid chromatography with photodiode-array detection. Journal of Chromatography A. 605(2). 221–225. 5 indexed citations

18.

Dotta, Francesco, Laurence B. Peterson, M. Previti, et al.. (1992). Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.. Endocrinology. 130(1). 37–42. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact